default author photo

Julien Grenier

Sainte Catherine Institute

SCHOLARLY PAPERS

2

DOWNLOADS

184

TOTAL CITATIONS

0

Scholarly Papers (2)

Association between Daily Timing of Everolimus Combined with Adjuvant Endocrine Therapy with Survival Outcomes in Patients with High-Risk Hormone Positive and Her2 Negative Early Breast Cancer: Results of a Sub-Study of the UCBG- UNIRAD Trial

Number of pages: 39 Posted: 27 Mar 2025
PSL Research University - Institut Curie, Institut Curie - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Medical Oncology Department, Sorbonne University - Hôpital Pitié-Salpêtrière, UNICANCER, Gustave Roussy - Breast Cancer Unit, University of Edinburgh - Edinburgh Cancer Centre, Institute of Cancer Research (ICR) - Clinical Trials and Statistics Unit (ICR-CTSU), University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, Armorican Center for Radiotherapy, Medical Imaging, and Oncology (CARIO), University of Paris-Saclay - Institut Gustave Roussy, Centre François Baclesse, University of Bordeaux - Institut Bergonié, Institut de Cancerologie de l’Ouest, Hôpital Universitaire Dupuytren, École Normale Supérieure - PSL Research University - Institut Curie, Clinique Pasteur, Sainte Catherine Institute, Institut Claudius Regaud - IUCT-Oncopole, CRCT, Inserm, Université Paris Cité, PSL Research University - Institut Curie, UNICANCER, Centre Jean Perrin, Université Paris Saclay and Hopital Saint-Louis
Downloads 104 (684,532)

Abstract:

Loading...

breast cancer, endocrine therapy, everolimus, circadian rhythm, intake timing

Association between Daily Timing of Everolimus Combined with Adjuvant Endocrine Therapy with Survival Outcomes in Patients with High-Risk Hormone Positive and Her2 Negative Early Breast Cancer: Results of a Sub-Study of the Ucbg- Unirad Trial

Number of pages: 39 Posted: 17 Apr 2025
PSL Research University - Institut Curie, Institut Curie - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Medical Oncology Department, Sorbonne University - Hôpital Pitié-Salpêtrière, UNICANCER, Gustave Roussy - Breast Cancer Unit, University of Edinburgh - Edinburgh Cancer Centre, Institute of Cancer Research (ICR) - Clinical Trials and Statistics Unit (ICR-CTSU), University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, Armorican Center for Radiotherapy, Medical Imaging, and Oncology (CARIO), University of Paris-Saclay - Institut Gustave Roussy, Centre François Baclesse, University of Bordeaux - Institut Bergonié, Institut de Cancerologie de l’Ouest, Hôpital Universitaire Dupuytren, École Normale Supérieure - PSL Research University - Institut Curie, Clinique Pasteur, Sainte Catherine Institute, Institut Claudius Regaud - IUCT-Oncopole, CRCT, Inserm, Université Paris Cité, PSL Research University - Institut Curie, UNICANCER, Centre Jean Perrin, University of Warwick - Cancer Chronotherapy Team and Hopital Saint-Louis
Downloads 39 (1,385,838)

Abstract:

Loading...

Breast cancer, endocrine therapy, everolimus, Circadian rhythm, intake timing

2.

Definition of Visceral Crisis in Hormone Receptor-Positive Her2-Negative Advanced Breast Cancer: Delphi Consensus Among Experts from the Unicancer French Breast Cancer Intergroup

Number of pages: 24 Posted: 06 Dec 2024
affiliation not provided to SSRN, University of Lille II - Centre Oscar Lambret, CHU Lille - Centre Oscar Lambret, École Normale Supérieure - PSL Research University - Institut Curie, PSL Research University - Institut Curie, Hopital Saint-Louis, Sainte Catherine Institute, Centre Eugene Marquis, Institut Curie - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Lille II - Centre Oscar Lambret, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 41 (1,196,171)

Abstract:

Loading...

Key words: advanced breast cancer, visceral crisis, consensus, Delphi method